Discover 472 paid clinical trials in Newport, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 472
FeaturedActive & Responsive
Low Intensity Focused Ultrasound: a New Paradigm for Depression and Anxiety
for
Depression
Location: 1 recruiting location
Sponsor: Ocean State Research Institute, Inc.
Sex: All
Age: 22 - 70+
Code: NCT05147142
Recruiting
Active & Responsive
Device Global Registry for the IlluminOss Bone Stabilization System
for
Traumatic Fracture, Pathological Fracture
Location: 11 recruiting locations
Sponsor: IlluminOss Medical, Inc.
Sex: All
Age: 50+
Code: NCT05206981
Recruiting
Active & Responsive
Pro-Change Population Health Solution
for
Risk Behavior
Location: 2 recruiting locations
Sponsor: Pro-Change Behavior Systems
Sex: All
Age: 21 - 70+
Code: NCT02755636
Phase2, Recruiting
Active & Responsive
A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age
for
SARS-CoV-2
Location: 26 recruiting locations
Sponsor: ModernaTX, Inc.
Sex: All
Age: 0 - 5
Code: NCT05436834
Phase3, Recruiting
Active & Responsive
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
for
Weight Loss
Location: 113 recruiting locations
Sponsor: Viking Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07104383
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
for
Pediatric Migraine
Location: 68 recruiting locations
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04649242
Phase3, Recruiting
Active & Responsive
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
for
Cough, Refractory Chronic Cough
Location: 47 recruiting locations
Sponsor: Bellus Health Inc. - a GSK company
Sex: All
Age: 18 - 70+
Code: NCT05600777
Phase3, Recruiting
Active & Responsive
A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma